rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kathleen E. Walsh

Director

Company insider

Files Form 4 as: Director, Beam Therapeutics; Director, LifeMD; Director, Wellcare Health Plans; Director, Navigant Consulting; Director, Imprivata.

In numbers

Trades disclosed
27
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
5
Companies where not an officer
5
First trade
24 Feb 2016
Last trade
3 Jun 2026
Last filed
5 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BEAM Beam TherapeuticsDirector · Genomics & Gene Editing · last 3 Jun 20260 buys · 0 sells
LFMD LifeMDDirector · Digital Health & Telemedicine · last 15 Dec 20220 buys · 0 sells
Wellcare Health PlansDirector · last 23 Jan 20200 buys · 0 sells
Navigant ConsultingDirector · last 11 Oct 20190 buys · 0 sells
ImprivataDirector · last 16 Sep 20160 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
3 Jun 2026filed 5 Jun 2026BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—19,676 at $0.00filing
3 Jun 2026filed 5 Jun 2026BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—19,676 at $0.00filing
4 Jun 2025filed 6 Jun 2025BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—33,662 at $0.00filing
5 Jun 2024filed 7 Jun 2024BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—23,114 at $0.00filing
—filed 8 Jun 2023BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—16,532 at $0.00filing
15 Dec 2022filed 23 Dec 2022LFMD LifeMDoption or derivative · Digital Health & TelemedicineSEC FORM 4 Code A—37,500 at $0.00filing
15 Dec 2022filed 23 Dec 2022LFMD LifeMDDigital Health & TelemedicineSEC FORM 4 Code A—75,000filing
1 Sep 2022filed 2 Sep 2022BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—10,391 at $0.00filing
10 Jun 2021filed 14 Jun 2021BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—3,126 at $0.00filing
10 Jan 2021filed 11 Jan 2021BEAM Beam Therapeuticsoption or derivative · Genomics & Gene EditingSEC FORM 4 Code A—11,609 at $0.00filing
23 Jan 2020filed 27 Jan 2020Wellcare Health PlansSEC FORM 4 Code D—1,512 at $0.00filing
11 Oct 2019filed 16 Oct 2019Navigant ConsultingSEC FORM 4 Code D—9,394filing
10 Oct 2019filed 11 Oct 2019Navigant ConsultingSEC FORM 4 Code G—4,923 at $0.00filing
13 Sep 2019filed 17 Sep 2019Navigant ConsultingSEC FORM 4 Code A—10 at $0.00filing
15 Jun 2019filed 18 Jun 2019Navigant ConsultingSEC FORM 4 Code A—12 at $0.00filing
22 May 2019filed 23 May 2019Wellcare Health Plansoption or derivativeSEC FORM 4 Code M—847 at $0.00filing
22 May 2019filed 23 May 2019Wellcare Health PlansSEC FORM 4 Code M—847 at $0.00filing
22 May 2019filed 23 May 2019Wellcare Health PlansSEC FORM 4 Code A—665 at $0.00filing
14 May 2019filed 15 May 2019Navigant ConsultingSEC FORM 4 Code A—5,440 at $0.00filing
15 Jun 2018filed 19 Jun 2018Navigant ConsultingSEC FORM 4 Code A—4,923 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John M. EvansCEO · CEO at Beam Therapeutics, filing Form 4 there in the last year
Bethany J. CavanaghSVP, Finance and Treasurer · SVP, Finance and Treasurer at Beam Therapeutics, filing Form 4 there in the last year
Giuseppe CiaramellaPresident · President at Beam Therapeutics, filing Form 4 there in the last year
Amy SimonChief Medical Officer · Chief Medical Officer at Beam Therapeutics, filing Form 4 there in the last year
FMR LLC10% owner and Other role · 10% owner and Other at Beam Therapeutics, filing Form 4 there in the last year